Table 4.
Effects of treatment scenario on willingness to undergo treatment and accuracy.
Willingness—% (n)† |
Accuracy—% (n)‡ |
|||||||
---|---|---|---|---|---|---|---|---|
Number and types of medication effects
|
Number and types of medication effects
|
|||||||
Summary statement | Control (C) | Mixed gain (MXG) | Multiple losses (ML) | Multiple gains (MG) | Control (C) | Mixed gain (MXG) | Multiple losses (ML) | Multiple gains (MG) |
Control | 60.8 (739)a | - | - | - | 77.2 (417)a | - | - | - |
No summary statement | - | 45.3 (702)b | 44.1 (700)b | 52.6 (667)a | - | 60.0 (395)b | 46.4 (418)c | 75.7 (362)a |
With summary statement | - | 45.2 (609)b | 42.5 (636)b | 59.8 (644)a | - | 66.3 (359)ab | 59.3 (371)bc | 75.1 (365)a |
Note. Willing participants are those who indicated that they would “probably” or “definitely” take the drug. Accurate participants are those who indicated that the treatment would reduce their overall risk of cancer (Waters et al., 2007a, 2007b).
Different superscripts for willingness indicate groups that differed from each other at p < .01 (Tukey adjusted).
Different superscripts for accuracy indicate groups that differed from each other at p < .0005 (Bonferroni-adjusted).